Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 12, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Immune Thrombocytopenic PurpuraSplenectomy; Status
Interventions
PROCEDURE

Immunolabeling

Immunolabeling of abnormalities observed by the cell study in flow cytometry.

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04056507 - Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura | Biotech Hunter | Biotech Hunter